Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/32567
Tipo
ArtículoDerechos de autor
Acceso abierto
Fecha del embargo
2020-04-15
Colecciones
- INI - Artigos de Periódicos [3464]
Metadatos
Mostrar el registro completo del ítem
IN VITRO SUSCEPTIBILITY OF ANTIFUNGAL DRUGS AGAINST SPOROTHRIX BRASILIENSIS RECOVERED FROM CATS WITH SPOROTRICHOSIS IN BRAZIL
Cats
Antifungal susceptibility
Sporotrichosis
Sporothrix schenckii complex
Autor
Afiliación
Federal University of Ceará. Specialized Medical Mycology Center. Postgraduate Program in Medical Microbiology. Fortaleza, CE, Brazil.
Federal University of São Paulo. Department of Microbiology, Immunology and Parasitology. Cellular Biology Division. São Paulo, SP, Brazil.
Federal University of Ceará. Specialized Medical Mycology Center. Postgraduate Program in Medical Microbiology. Fortaleza, CE, Brazil.
Federal University of Ceará. Specialized Medical Mycology Center. Postgraduate Program in Medical Microbiology. Fortaleza, CE, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Federal University of São Paulo. Department of Microbiology, Immunology and Parasitology. Cellular Biology Division. São Paulo, SP, Brazil.
Federal University of São Paulo. Department of Microbiology, Immunology and Parasitology. Cellular Biology Division. São Paulo, SP, Brazil.
Federal University of Ceará. Specialized Medical Mycology Center. Postgraduate Program in Medical Microbiology. Fortaleza, CE, Brazil.
Federal University of Ceará. Specialized Medical Mycology Center. Postgraduate Program in Medical Microbiology. Fortaleza, CE, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Federal University of São Paulo. Department of Microbiology, Immunology and Parasitology. Cellular Biology Division. São Paulo, SP, Brazil.
Resumen en ingles
Sporotrichosis is an important subcutaneous mycosis of humans and animals. Classically, the disease is acquired upon traumatic inoculation of Sporothrix propagules from contaminated soil and plant debris. In addition, the direct horizontal transmission of Sporothrix among animals and the resulting zoonotic infection in humans highlight an alternative and efficient rout of transmission through biting and scratching. Sporothrix brasiliensis is the most virulent species of the Sporothrix schenckii complex and is responsible for the long-lasting outbreak of feline sporotrichosis in Brazil. However, antifungal susceptibility data of animal-borne isolates is scarce. Therefore, this study evaluated the in vitro activity of amphotericin B, caspofungin, itraconazole, voriconazole, fluconazole, and ketoconazole against animal-borne isolates of S. brasiliensis. The susceptibility tests were performed through broth microdilution (M38-A2). The results show the relevant activity of itraconazole, amphotericin B, and ketoconazole against S. brasiliensis, with the following MIC ranges: 0.125-2, 0.125-4 and 0.0312-2 μg/ml, respectively. Caspofungin was moderately effective, displaying higher variation in MIC values (0.25-64 μg/ml). Voriconazole (2-64 μg/ml) and fluconazole (62.5-500 μg/ml) showed low activity against S. brasiliensis strains. This study contributed to the characterization of the in vitro antifungal susceptibility of strains of S. brasiliensis recovered from cats with sporotrichosis, which have recently been considered the main source of human infections.
Palabras clave en ingles
Sporothrix brasiliensisCats
Antifungal susceptibility
Sporotrichosis
Sporothrix schenckii complex
Compartir